Alkermes, Inc. (NASDAQ: ALKS) announced today that its corporate
presentation will be webcast live by Morgan Stanley on Tuesday,
September 9, 2008 at 9:45 a.m. EDT and by Robert W. Baird on Wednesday,
September 10, 2008 at 12:40 p.m. EDT. The presentations will be webcast
from New York City and may be accessed under the investor relations tab
at www.alkermes.com. The
presentations will be archived for 14 days.
Alkermes, Inc., a biotechnology company committed to developing
innovative medicines to improve patients’
lives, manufactures RISPERDAL®
CONSTA® for
schizophrenia and developed and manufactures VIVITROL®
for alcohol dependence. Alkermes’ robust
pipeline includes extended-release injectable, pulmonary and oral
products for the treatment of prevalent, chronic diseases, such as
central nervous system disorders, addiction and diabetes. Headquartered
in Cambridge, Massachusetts, Alkermes has research and manufacturing
facilities in Massachusetts and Ohio.
Alkermes, Inc.
Eva Stroynowski, 617-583-6823
Corporate
Communications
